Command Palette

Search for a command to run...

Vanta Bioscience Ltd.
22.65(-9.98%)
1W: +3.84%

Vanta Bioscience Peer Comparison

Snapshot Summary

Vanta Bioscience Ltd. shows extreme financial distress with negative growth metrics and high debt levels, positioning it as a high-risk investment. However, its low price-to-book and price-to-sales ratios suggest a potential for value recovery if operational issues are addressed. Syngene International Ltd. stands out as a strong performer with solid profitability and growth metrics.

  • Vanta Bioscience has the lowest revenue growth and EPS, along with the highest debt-to-equity ratio among peers.
  • Syngene International leads in profitability with strong ROE and revenue growth.
  • Just Dial is a value pick with the lowest PE ratio, indicating potential undervaluation.
  • Syngene International Ltd.: Highest ROE and revenue growth, indicating strong profitability and operational efficiency.
  • International Gemmological Institute (India) Ltd.: Strong ROE and zero debt, showcasing exceptional financial health.
  • CMS Info Systems Ltd.: Solid profitability and reasonable valuation metrics, making it an attractive investment.
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
Vanta Bioscience Ltd.₹22.03₹13.91Cr307.25-4.08%4.02
SYNGENE₹635.10₹25,565.12Cr54.6715.55%0.03
SAGILITY₹45.07₹21,098.75Cr77.7210.14%0.10
IGIL₹346.20₹14,961.38Cr34.06105.44%-
LATENTVIEW₹412.90₹8,530.56Cr96.2515.51%0.00
JUSTDIAL₹814.40₹6,925.84Cr11.4912.37%-
CMSINFO₹416.75₹6,854.39Cr20.7027.54%-

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.